TAS-114
TAS-114 is an orally active dual dUTPase/dihydropyrimidine dehydrogenase (DPD) inhibitor, can improving the therapeutic efficacy of fluoropyrimidine[1].
Product Specifications
CAS Number
1198221-21-4
UNSPSC
12352005
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tas-114.html
Purity
99.89
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(CCCOCN(C(N1)=O)C=CC1=O)(N[C@@H](C2=CC=CC(OC3CCCC3)=C2)C)=O
Molecular Formula
C21H29N3O6S
Molecular Weight
451.54
References & Citations
[1]Yano W, et al. TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy. Mol Cancer Ther. 2018 Aug;17 (8) :1683-1693.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-V096270-25MG 25 mg
L-Valyl-L-histidyl-L-leucyl-L-threonyl-L-prolyl-L-glutamic Acid Trifluoroacetate
Sign In for Pricing
View Details 
BNC040747-500 1x 500 µL
CD66 (CEA) (COL-1 + CEA31 + C66/261), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
